idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
11.05.2015 18:22

MDC and Charité Researchers Identify Gene Responsible for Hypertension and Brachydactyly

Barbara Bachtler Pressestelle
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft

    Individuals with this altered gene have hereditary hypertension and a skeletal malformation called brachydactyly type E, which is characterized by unusually short fingers and toes. The effect on blood pressure is so serious that – if left untreated – it most often leads to death before age fifty. After more than 20 years of research, scientists of the Experimental and Clinical Research Center (ECRC), a joint cooperation between the Max Delbrück Center (MDC) and the Charité – Universitätsmedizin Berlin have now identified the gene that causes this rare syndrome (Nature Genetics online doi:10.1038/ng.3302)*.

    In six families not related to each other they discovered different point mutations in the gene PDE3A. These mutations always lead to high blood pressure and shortened bones of the extremities, particularly the metacarpal and metatarsal bones. This syndrome is the first Mendelian hypertension (salt-resistant) not based on salt reabsorption but instead is more directly related to resistance in small blood vessels.

    “In 1994, when we began with the study of this disease and examined the largest of the affected families in Turkey for the first time, modern DNA sequencing methods did not yet exist. Extensive gene databases to facilitate the search for the cause of this genetic disease were also lacking back then,” said PD Dr. Sylvia Bähring, senior author of the research group’s publication headed by Professor Friedrich C. Luft.

    “Veritable treasure trove for genetics”
    In 1996, the research group succeeded in comparing the genetic material of healthy and diseased family members in order to localize the chromosome region where this disease gene must reside. The region they detected was on a segment of chromosome 12 and was an estimated 10 million base pairs in size. “Ultimately however,” said Dr. Bähring, “a 16-year-old Turkish boy helped us to pinpoint this gene. He is a veritable treasure trove for the field of genetics.” He also has severe high blood pressure – like all other test subjects he is being treated anti-hypertensive drugs –- but his hands are nearly normal. Only the metacarpal bones of his little fingers are slightly shortened.

    Whole-genome sequencing of the DNA from several people with the syndrome recently enabled Dr. Philipp G. Maass, Dr. Atakan Aydin, Professor Luft, Dr. Okan Toka (formerly MDC/Charité, now the University of Erlangen), Dr. Carolin Schächterle (MDC research group Dr. Enno Klußmann) and Dr. Bähring to identify the gene and six different point mutations in a total of six families from around the world. It is the gene PDE3A, which contains the blueprint for the enzyme, phosphodiesterase 3A. The six different point mutations, which the researchers pinpointed in the PDE3A gene, lead to the exchange of a single DNA building block that is different in each family. In each case, one amino acid of the enzyme is exchanged.

    One gene – two different syndromes
    But how can one mutated gene cause two quite different diseases such as hypertension and brachydactyly? The ECRC researchers also provide the explanation for this in their study. The task of the phosphodiesterase encoded by the PDE3A gene is to control the quantity of the two secondary messenger proteins present in each cell, cAMP (cyclic adenosine monophosphate) and cGMP (cyclic guanosine monophosphate), and thus to regulate the duration of their activity.

    The mutations in the gene PDE3A, however, cause the enzyme phosphodiesterase to be overexpressed. Thus, it modulates too much of the secondary messenger protein cAMP (cyclic adenosine monophosphate) into AMP (adenosine monophosphate). As a result, the cell has less cAMP at its disposal. The consequence is that, in the affected family members, the smooth muscle cells of the vascular wall of small arteries divide to a greater extent. This proliferation leads to a thickening of the vascular muscle layer, and the blood vessels narrow and stiffen, resulting in high blood pressure. Furthermore, a too low cAMP level in the vascular muscle cells also leads to increased narrowing of the blood vessels.

    But what effect do the lowered cAMP levels have on the development of the bones of the extremities? The gene that elicits the skeletal malformation brachydactyly type E is PTHLH (parathyroid hormone-like hormone). In the cartilage cells, a transcription factor (CREB), activated by cAMP, binds in the control region of the gene. This factor ensures that the gene is transcribed and can affect the growth of the cartilage. If there is less cAMP in the cartilage cell, this mechanism is disturbed. This situation then leads to the shortening of the metacarpals and metatarsals, namely the fingers and toes. Thus, by varying the cellular signal transduction, one point mutation can elicit two different characteristics in one and the same person.

    New perspectives on hypertension development
    The researchers point out that hypertension in the families they examined is not linked to dietary salt intake. The consensus of researchers so far has been that too much salt in the diet damages the kidneys and drives blood pressure up. “We have shown in our study that for the development of the inheritable form of hypertension only the blood vessels are of significance and not directly the kidneys,” said Dr. Bähring, stressing the importance of this study.

    First description of the disease in 1973
    In 1973, the Turkish physician, Professor Nihat Bilginturan, of the Haceteppe University in Ankara, Turkey first described the disease whose genetic cause has now been elucidated by the researchers in Berlin. Dr Bilginturan noted that in an extended family living on the coast of the Black Sea several family members had shortened fingers and toes – the medical term for this syndrome is brachydactyly (from Greek: brachus for short and daktylos for finger). Remarkably, the affected family members also had severe high blood pressure from youth on and died at a relatively young age. Untreated, their blood pressure exceeded the normal level of 140/90 mm Hg by an average of 50 mm Hg, leading to death before the age of 50, usually due to stroke. The geneticist Professor Thomas Wienker (formerly of the MDC and the University of Bonn, now at the Max Planck Institute for Molecular Genetics, Berlin) discovered Bilginturan’s publication and set the wheels of research in motion.

    *PDE3A mutations cause autosomal-dominant hypertension with brachydactyly
    Philipp G. Maass1,2,36, Atakan Aydin1,2,36, Friedrich C. Luft1,2,3,36*, Carolin Schächterle2,36,Anja Weise4, Sigmar Stricker5,6, Carsten Lindschau7,8, Martin Vaegler1,9, Fatimunnisa Qadri1,2, Hakan R. Toka10,11, Herbert Schulz2,12, Peter M. Krawitz5,13,14, Jochen Hecht5,14, Irene Hollfinger2, Yvette Wefeld-Neuenfeld2, Eireen Bartels-Klein2, Astrid Mühl2, Martin Kann15, Herbert Schuster16, David Chitayat17,18, Martin G. Bialer19, Thomas F. Wienker5,20, Jürg Ott21,22, Katharina Rittscher4, Thomas Liehr4, Jens Jordan23, Ghislaine Plessis24, Jens Tank23, Knut Mai1, Ramin Naraghi24, Russell Hodge2, Maxwell Hopp26, Lars O. Hattenbach27, Andreas Busjahn28, Anita Rauch29, Fabrice Vandeput30,31, Maolian Gong1,2, Franz Rüschendorf2, Norbert Hübner2,32,33, Hermann Haller7, Stefan Mundlos5,13,14, Nihat Bilginturan34, Matthew A. Movsesian30,31, Enno Klussmann2,32, Okan Toka35, and Sylvia Bähring1,2,36
    1Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany
    2Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany
    3Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA
    4Jena University Hospital, Friedrich Schiller University, Institute of Human Genetics, Jena, Germany
    5Max Planck Institute for Molecular Genetics, Berlin, Germany
    6Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany
    7 Department of Nephrology, Hannover University Medical School, Hannover, Germany
    8Staatliche Technikerschule Berlin, Berlin
    9University Department of Urology, Laboratory of Tissue Engineering, Eberhard Karls University Tübingen, Tübingen, Germany
    10 Eastern Virginia Medical School, Division of Nephrology and Hypertension, 855 W Brambleton Ave, Norfolk, VA, USA
    11Brigham and Women’s Hospital, Division of Nephrology, MRB4, Boston, MA, USA
    12University of Cologne, Cologne Center for Genomics (CCG), Cologne, Germany
    13Institute for Medical Genetics and Human Genetics, Charité – Universitätsmedizin Berlin, Germany
    14Berlin Brandenburg Center for Regenerative Therapies (BCRT), Charité – Universitätsmedizin Berlin, Germany
    15Department II of Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
    16INFOGEN, Berlin, Germany
    17The Hospital for Sick Children, Department of Pediatrics, Division of Clinical and Metabolic Genetics, University of Toronto, Ontario, Canada
    18The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Ontario, Canada
    19Division of Medical Genetics and Department of Pediatrics, North Shore/LIJ Health System, Manhasset, NY, USA
    20Institute for Medical Biometry, Informatics and Epidemiology, University of Bonn, Germany
    21Institute of Psychology, Chinese Academy of Sciences, Beijing, China
    22Statistical Genetics, Rockefeller University New York, NY, USA
    23Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany
    24Centre Hospitalier Universitaire de Caen, Cytogénétique postnatale et génétique Clinique, Caen, France
    25Department of Neurosurgery, Bundeswehrkrankenhaus Ulm, Germany
    26Griffith Base Hospital, Department of Pediatrics, Griffith, NSW, Australia
    27Department of Ophthalmology, Hospital Ludwigshafen, Ludwigshafen, Germany
    28HealthTwist GmbH, Berlin, Germany
    29Institute for Medical Genetics, University of Zurich, Switzerland
    30Cardiology Section, VA Salt Lake City Health Care System, Salt Lake City, UT, USA
    31Departments of Internal Medicine and Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA
    32DZHK, German Centre for Cardiovascular Research, Berlin, Germany
    33Charité – Universitätsmedizin, Berlin, Germany
    34Department of Pediatric Endocrinology, Hacettepe University, Turkey
    35Childrens Hospital, Department of Pediatric Cardiology, Friedrich-Alexander University Erlangen, Germany
    36The authors contributed equally to this work.

    Contact:
    Barbara Bachtler
    Press Department
    Max Delbrück Center for Molecular Medicine in the Helmholtz Association
    Robert-Rössle-Straße 10
    13125 Berlin
    Germany
    Phone: +49 (0) 30 94 06 - 38 96
    Fax: +49 (0) 30 94 06 - 38 33
    e-mail: presse@mdc-berlin.de
    https://www.mdc-berlin.de/en


    Bilder

    Shortened fingers (brachydactyly), are always inherited in a Turkish family with hypertension. Above the hands of a woman with the disease, below the hands of a healthy woman as comparison.
    Shortened fingers (brachydactyly), are always inherited in a Turkish family with hypertension. Above ...
    (Photo: Hakan Toka/ Copyright: MDC)
    None


    Merkmale dieser Pressemitteilung:
    Journalisten, Wissenschaftler
    Biologie, Medizin
    überregional
    Forschungsergebnisse, Wissenschaftliche Publikationen
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).